Abstract | BACKGROUND/AIM: DESIGN/METHODS: Five cross-sectional screenings were performed on teenagers born from 1984 to 1993. We examined hepatitis B surface antigen ( HBsAg), anti-hepatitis C virus (anti-HCV), ALT and body mass index, and additionally checked hepatitis B envelope antigen ( HBeAg) for positive HBsAg and HCV RNA for positive anti-HCV. Teenagers with ALT elevation underwent an ultrasonography examination. RESULTS: This study enrolled 1788 (93.7%) of 1909 students, discovering individual prevalence of HBsAg (6.3%), anti- hepatitis B core (anti-HBc) (15.5%), anti-HCV (2.2%), overweight (22.4%), obesity (12.8%) and ALT >40 IU/L (3.7%). HBsAg and anti-HBc prevalence declined with trends, while obesity increased with trends (P<0.001). Among 66 ALT-elevated teenagers, prevalence percentages of risk factors were HBsAg (22.7%), anti-HCV (1.5%), obesity (45.5%), HBsAg with obesity (7.6%) and anti-HCV with obesity (3.0%). Additionally, obesity showed predominance (85.7%) among aetiologies of teenagers with fatty livers (60.9%). The independently associated factors of ALT elevation included being male (odds ratio, 2.18; 95% confidence interval, 1.21-3.93), HBsAg (4.25; 1.06-17.13), HBeAg (7.24; 1.64-31.9), HCV RNA (29.03; 5.8-145.29) and obesity (16.5; 8.79-30.98). CONCLUSION: In place of viral hepatitis, obesity is becoming the major aetiology of abnormal liver function among the young generation in a previously hepatitis-endemic area.
|
Authors | Jung-Ta Kao, Jing-Houng Wang, Chao-Hung Hung, Tsung-Hui Hu, Chuan-Mo Lee, Shu-Fen Hung, Sheng-Nan Lu |
Journal | Liver international : official journal of the International Association for the Study of the Liver
(Liver Int)
Vol. 28
Issue 9
Pg. 1298-304
(Nov 2008)
ISSN: 1478-3231 [Electronic] United States |
PMID | 18662273
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hepatitis B Vaccines
- Alanine Transaminase
|
Topics |
- Adolescent
- Alanine Transaminase
(blood)
- Body Mass Index
- Child
- Cross-Sectional Studies
- Endemic Diseases
(prevention & control)
- Female
- Hepatitis B
(epidemiology)
- Hepatitis B Vaccines
- Hepatitis C
(epidemiology)
- Humans
- Liver Diseases
(blood, etiology)
- Male
- Obesity
(blood, complications)
- Prevalence
- Taiwan
(epidemiology)
|